Galectin TherapeuticsGALT
那斯達克 · USD
3.12
+0.32
(+11.43%)
收盤 06/24 03:59 (UTC+8)
盤後
3.32
+0.20
(+6.41%)
06/24 03:59 (UTC+8)
Galectin TherapeuticsGALT
3.12
+0.32
(+11.43%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 4,077 | 3,365 | 4,198 | 4,625 | - | - | - | - | 9,648 | 9,561 |
研發費用 | 2,231 | 1,933 | 2,611 | 3,261 | 6,485 | 11,109 | 7,595 | 9,813 | 8,054 | 8,228 |
推銷及管理費用 | 1,846 | 1,432 | 1,587 | 1,364 | 1,412 | 1,319 | 1,471 | 1,478 | 1,594 | 1,333 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -4,077 | -3,365 | -4,198 | -4,625 | -7,897 | -12,428 | -9,066 | -11,291 | -9,648 | -9,561 |
其他收入及費用 | 1,019 | -196 | -2,166 | -1,070 | 10 | 2,186 | -660 | 189 | -789 | 411 |
利息費用 | 1,988 | 1,939 | 1,820 | 1,826 | 1,744 | 1,725 | 1,494 | 1,269 | 1,052 | 847 |
稅前純益 | -5,046 | -5,500 | -8,184 | -7,521 | -9,631 | -11,967 | -11,220 | -12,371 | -11,489 | -9,997 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -5,046 | -5,500 | -8,184 | -7,521 | -9,631 | -11,967 | -11,220 | -12,371 | -11,489 | -9,997 |
基本每股稅後盈餘(元) | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 | -0.19 | -0.18 | -0.20 | -0.19 | - |
稀釋每股稅後盈餘(元) | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 | -0.19 | -0.18 | -0.20 | -0.19 | -0.16 |
基本平均股數(千股) | 65782.00 | 64756.00 | 64205.00 | 63447.00 | 63204.00 | 62749.00 | 62278.00 | 62233.00 | 61976.00 | - |
稀釋平均股數(千股) | 65782.00 | 64756.00 | 64205.00 | 63447.00 | 63204.00 | 62749.00 | 62278.00 | 62233.00 | 61976.00 | - |
還原基本每股稅後盈餘(元) | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 | -0.19 | -0.18 | -0.20 | -0.19 | - |
還原稀釋每股稅後盈餘(元) | -0.08 | -0.08 | -0.13 | -0.12 | -0.15 | -0.19 | -0.18 | -0.20 | -0.19 | -0.16 |
還原基本平均股數(千股) | 65,782 | 64,756 | 64,205 | 63,447 | 63,204 | 62,749 | 62,278 | 62,233 | 61,976 | - |
還原稀釋平均股數(千股) | 65,782 | 64,756 | 64,205 | 63,447 | 63,204 | 62,749 | 62,278 | 62,233 | 61,976 | - |
EBITDA(千元) | -3,046 | -3,520 | -6,364 | -5,693 | -7,877 | -10,232 | -9,717 | -11,093 | -10,428 | -9,141 |